Quantcast

Latest Clinical pharmacology Stories

2014-06-02 08:29:47

BUENA, N.J., June 2, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its second abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions to fifteen, with thirteen now pending at the FDA. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO Jason Grenfell-Gardner, President and...

2014-05-29 08:29:36

REDWOOD CITY, Calif., May 29, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 3rd. Presentation details are as follows: Jefferies Global Healthcare ConferenceDate: June 3, 2014Location: Grand Hyatt New YorkPresentation Time: 1:30...

2014-05-28 23:15:56

Transvaginal Mesh Attorneys Babbitt, Johnson, Osborne and Le Clainche explain the FDA proposal to reclassify surgical mesh to a “high risk” device for pelvic organ prolapse (POP). West Palm Beach, Florida (PRWEB) May 28, 2014 After six years and thousands of lawsuits for transvaginal mesh injuries, the U.S. Food and Drug Administration (FDA) is proposing to reclassify surgical mesh for pelvic organ prolapse (POP) repair to a “high-risk device.” A physician’s news service called,...

2014-05-28 23:15:37

Based on the FDA’s most recent recall guidance, devicemakers now have to wonder if their product enhancements are an acceptable product enhancement, a recall, a product enhancement that’s now considered a recall, or neither a product enhancement nor a recall. This webinar explains the differences on how current or future product enhancements might be viewed by FDA. Falls Church, VA (PRWEB) May 28, 2014 Medical Device Recall or Product Enhancement?: Understanding When to Submit a Part...

2014-05-28 23:08:35

PatientsLikeMe co-founder, Pfizer executive and top regulator champion collaboration. Washington (PRWEB) May 28, 2014 Global innovators in pioneering drug development and access will lead the DIA 2014 50th Annual Meeting in San Diego from June 15 to 19. Freda C. Lewis-Hall, executive vice president and chief medical officer of Pfizer Inc., and Sandra Kweder, deputy director of the Office of New Drugs for the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research,...

2014-05-28 12:33:14

FALLS CHURCH, Va., May 28, 2014 /PRNewswire-iReach/ -- 11(th) Annual Medical Device Quality Congress: Managing the "Big Five" Quality Concerns **Presented by FDAnews** June 24-26, 2014 - Bethesda, MD www.fdanews.com/MDQCKeynoteSpeaker Photo - http://photos.prnewswire.com/prnh/20140528/91797 FDAnews is pleased to announce that Steven Silverman, Director, Office of Compliance, CDRH, FDA has been selected to present the keynote address at the 11(th) Annual Medical Device Quality Congress. As...

2014-05-27 23:01:13

Over the past 10 years, thousands of device professionals have attended Medical Device Quality Congress (MDQC) and benefited from the unmatched educational sessions presented by FDA officials and industry experts. This year’s keynote speaker is CDRH’s Director of Compliance Steve Silverman. Falls Church, VA (PRWEB) May 27, 2014 Managing the “Big Five” Quality Concerns **Presented by FDAnews** June 24-26, 2014 – Bethesda, MD http://www.fdanews.com/MDQCKeynote FDAnews is pleased...

2014-05-27 08:29:32

To lead integration of Company's global scientific expertise and services to meet end-to-end customer drug development needs BOSTON, May 27, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today named Dr. Sy Pretorius its Chief Scientific Officer. Dr. Pretorius currently serves as the Company's Corporate Vice President and Worldwide Head of Early Phase, and will continue in that capacity in addition to assuming his...

2014-05-21 08:29:59

RYE, N.Y., May 21, 2014 /PRNewswire/ -- Curemark, a leading drug research and development company focused on the treatment of neurological and other diseases, announced today that the company was named a Red Herring Top 100 North American award-winner. "We believe that Curemark embodies the vision, drive, and innovation that define a successful entrepreneurial venture. Curemark should be proud of its accomplishment as the competition was very strong," stated Alex Vieux, published...

2014-05-20 23:14:46

Over the past 10 years, thousands of device professionals have attended Medical Device Quality Congress (MDQC) and benefited from the unmatched educational sessions presented by industry experts and FDA officials. For 2014, FDAnews has crafted a groundbreaking three-day agenda that will provide a thorough overview of all the key issues confronting devicemakers, with actionable information and insights that can be taken back and applied immediately. Falls Church, VA (PRWEB) May 20, 2014...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related